Literature DB >> 2016218

Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.

G L Hanna1, J T McCracken, D P Cantwell.   

Abstract

Basal prolactin concentrations were measured before treatment in 18 children and adolescents with obsessive-compulsive disorder as well as in 15 of these patients after 4 and 8 weeks of clomipramine treatment. Basal prolactin levels were influenced by a history of chronic tic disorder and by the duration and severity of obsessive-compulsive symptoms. Clomipramine administration significantly increased basal prolactin levels. A slight decline in prolactin levels during the last 4 weeks of clomipramine treatment was positively correlated with a favorable treatment response and negatively correlated with duration of illness. If the changes in prolactin levels observed during clomipramine treatment are due primarily to changes in serotonergic neurotransmission, these data suggest that clomipramine treatment of obsessive-compulsive disorder produces an adaptive decrease in the responsiveness of serotonergic receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016218     DOI: 10.1097/00004583-199103000-00002

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  3 in total

1.  Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder.

Authors:  Susanne E Ahmari; Victoria B Risbrough; Mark A Geyer; H Blair Simpson
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

2.  Obsessive compulsive neurosis : clomipramine, prolactin and therapeutic response.

Authors:  J Ananth; A Kaur; R Poland; M Wohl
Journal:  Indian J Psychiatry       Date:  1997-04       Impact factor: 1.759

3.  Error-related negativity and tic history in pediatric obsessive-compulsive disorder.

Authors:  Gregory L Hanna; Melisa Carrasco; Shannon M Harbin; Jenna K Nienhuis; Christina E LaRosa; Poyu Chen; Kate D Fitzgerald; William J Gehring
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-07-25       Impact factor: 8.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.